Skip to main content

4 articles related to "Zolgensma"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 07 Jan 2025

Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database

in Pharmacoepidemiology

Wenwen Zhang
Yizhen Yin
Dan Yang
Mengyuan Liu
Caixia Ye
Ruiling Yan
Ruiman Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475884

7,537 views
7 citations

Case Report

Published on 12 Sep 2023

Case report: A case of spinal muscular atrophy in a preterm infant: risks and benefits of treatment

in Neuromuscular Disorders and Peripheral Neuropathies

Elisa Nigro
Eyal Grunebaum
Binita Kamath
Christoph Licht
Caroline Malcolmson
Aamir Jeewa
Craig Campbell
Hugh McMillan
Pranesh Chakraborty
Mark Tarnopolsky

Frontiers in Neurology

doi 10.3389/fneur.2023.1230889

5,686 views
12 citations

Review

Published on 23 Nov 2020

New Therapeutics Options for Pediatric Neuromuscular Disorders

in Pediatric Neurology

Marina Flotats-Bastardas
Andreas Hahn

Frontiers in Pediatrics

doi 10.3389/fped.2020.583877

10,899 views
16 citations

General Commentary

Published on 17 May 2022

Commentary: Current Status of Gene Therapy for Spinal Muscular Atrophy

in Cellular Neuropathology

Wilfried Rossoll
Ravindra N. Singh

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2022.916065

4,959 views
5 citations